The article “Cardiometabolic Risk Factors Increase Likelihood of Liver Fibrosis More in Women Than Men” from March 16, 2026, is revealing. It’s from a study published in JAMA Network Open.
🔬 What the study found
- Based on a large U.S. dataset (~6,000 adults), researchers examined how common metabolic risk factors relate to liver fibrosis.
- Women showed a stronger increase in fibrosis risk from several key factors:
- High waist circumference (central obesity)
- Glucose intolerance / diabetes
- Having ≥2 cardiometabolic risk factors
- Example:
- High waist circumference increased fibrosis odds ~13× in women vs ~4× in men
⚖️ Important nuance
- Men still had higher overall rates of fibrosis, but
- Women were more sensitive to the same risk factors, meaning their risk rises more sharply when these conditions are present
🧬 Why this matters
- Suggests sex-specific biology affects how metabolic disease drives liver damage
- Indicates potential under-recognition of risk in women
- Highlights need for earlier screening and targeted prevention strategies, especially in women with metabolic risk factors
🩺 Clinical implication
- Clinicians may need to:
- Treat cardiometabolic risk more aggressively in women
- Use sex-specific risk stratification for liver disease.